Pingping Dai

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

Hao Sun, Si‐Yang Maggie Liu, Jiaying Zhou et al. · EBioMedicine · 2020 · 251 citations · Full text

Medicine, Molecular Biology, Oncology +17

Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non–Small Cell Lung Cancer

Jia‐Tao Zhang, Si‐Yang Liu, Wei Gao et al. · Cancer Discovery · 2022 · 222 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Life cycle carbon emission flow analysis for electricity supply system: A case study of China

G. Chen, B. Chen, Hao Zhou et al. · Energy Policy · 2013 · 51 citations

Management, Environmental Engineering, Environmental Sciences +14

Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing

Yanfang Guan, Hong Hu, Yin Peng et al. · Familial Cancer · 2014 · 30 citations

Life Sciences, Genetics, Molecular Genetics +17

Clinical and genomic features of Chinese lung cancer patients with germline mutations

Wenying Peng, Bin Li, Jin Li et al. · Nature Communications · 2022 · 30 citations · Full text

Medicine, Genetics, Oncology +17